Wednesday, January 27th | 14 Shevat 5781

Subscribe
January 12, 2021 10:55 am

Israel Expects to Start Vaccinating Children by March, Virus Chief Says

avatar by Reuters and Algemeiner Staff

A medical worker prepares to administer a second vaccination injection against the coronavirus disease as Israel continues its national vaccination drive, during a third national COVID-19 lockdown, at Tel Aviv Sourasky Medical Center (Ichilov Hospital) in Tel Aviv, Israel January 10, 2021. Photo: REUTERS/ Ronen Zvulun.

Israel may include children over the age of 12 in groups receiving COVID-19 vaccines within the next two months if research shows this is safe, a top health official said on Tuesday.

Vaccinating at a world-record pace, Israel says it aims to have administered one or both shots to 5 million of its 9 million citizens, and reopen the economy, by mid-March.

Elderly Israelis and adults with medical conditions or jobs in critical high-risk sectors have been given priority. But with Israeli officials anticipating more regular vaccine shipments, the eligibility categories have been expanded.

Nachman Ash, national coordinator on the pandemic, predicted that pharmacological research would establish that the minimum age threshold for the vaccines could be safely lowered from 16 to 12, and FDA approval for such use secured, by March.

Related coverage

January 27, 2021 2:56 pm
0

Netanyahu Will Seek to Avoid a Confrontation With Biden on Iran Nuclear Issue: Report

Israeli Prime Minister Benjamin Netanyahu will seek to avoid a confrontation with the new Biden administration on the Iran nuclear...

“The fact that children under the age of 16 are not currently getting vaccinated is certainly troubling, in terms of the ability to achieve herd immunity,” he told 103 FM radio.

“I reckon that, in another month or two, there will be another cohort — the aged-12 and higher — that we can vaccinate.”

Around 7.75 percent of Israel’s population are between the ages of 12 and 16, according to Central Bureau of Statistics data.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.